Slide 1: Hydrix Limited Investor Presentation October 2019
For personal use only Hydrix Limited Hydrix brings technologies to life which enhance people’s health, safety and well-being Investor Presentation October 2019 Page 1 Hydrix Ltd | Investor Presentation | October 2019
Slide 2: Hydrix unique value proposition: bringing client technologies to life
Hydrix unique value proposition is bringing client technologies to life which aim to solve complex global problems For personal use only Our core areas of expertise are within large addressable, global, high growth sectors Medical Technology Defence & Aerospace Selection of our Clients • Cardiology
Slide 3: Hydrix leverages talent and know-how to deliver novel solutions
Hydrix leverages its talent & know-how acquired through diverse customer engagements to deliver novel solutions For personal use only Diverse skill sets & subject matter expertise applied across products and industries Medical Technology Consumer & Industrial Defence & Aerospace Engineering Expertis
Slide 4: Consistent strong quarterly revenue growth
Hydrix has delivered consistent strong quarterly revenue growth For personal use only Quarterly Revenue ($m) $4.5m $4.0m 4.2m $3.5m 3.5m $3.0m 3.1m $2.5m 2.7m $2.0m 2.0m 2.0m $1.5m 1.4m $1.0m $0.5m $0.0m Dec-17 Mar-18 Jun-18 Sep-18 Dec-18 Mar-19 Jun-19 Panorama Synergy (PSY) PSY rebrands as acquires
Slide 5: All milestones were exceeded during FY19
All milestones were exceeded during FY19 For personal use only Milestones - FY19 Achievements Minimum 15% revenue growth Exceeded each half year growth target by over two times Exceeded → over prior half year period Full year revenue growth of 149% (FY19: $14.23m, FY18: $5.7m) 15% increase in engine
Slide 6: FY20 milestones and progress to date
FY20 milestones and progress to date For personal use only Milestones for FY20 Status Revenue growth to exceed 15% over FY19 On Track Deliver a full year cash operating profit1 On Track Implement one ‘Buy, Build & Invest’ strategy On Track FY20 Progress – Pipeline / Contracts FY20 Progress – Financi
Slide 7: Meaningful progress implementing new Buy, Build & Invest strategy
Meaningful progress implementing new Buy, Build & Invest strategy For personal use only By accessing highly valuable early stage technology and leveraging design, engineering and commercialisation capabilities, Hydrix is expanding its revenue streams Capital Gains Value driven from equity investment
Slide 8: Angel Medical Systems (AngelMed) – Guardian device
Angel Medical Systems (AngelMed) – Guardian® device For personal use only • Guardian® is the world’s first FDA (PMA) approved implantable cardiac monitor and patient alerting system • Guardian® uses AI machine learning based algorithms to accurately detect changes to the heart-beat indicative of a p
Slide 9: Accelerating Hydrix market value through services growth and income platforms
Accelerating Hydrix market value through double-digit services growth and creating additional income platforms For personal use only Buy, Build, & Invest strategy progress since acquiring Hydrix Gyder Surgical Example: HYD acquisition, Nov 17 Memphasys AngelMed a Fee-for-Services only ~1% equity Up
Slide 10: The Hydrix customer journey
The Hydrix CUSTOMER journey Indicative ‘value creation’ For personal use only 1. innovation 2. Design 3. Engineer 4. Prototype 5. Manufacture Insights Conceptual design Software Test rigs Design for Research Contextual enquiry Electronics Proof-of-principle Manufacture, User Experience Models and mo
Slide 11: Medical Technology – Specialties in solving global healthcare problems
Medical Technology – Specialties in solving global healthcare problems For personal use only Global demand to help solve the world’s healthcare problems & improve patient outcomes Expertise in Cardiac technology “We concluded that the Hydrix team’s collaborative approach, controller development expe
Slide 12: Medical Device Technology - Case Studies
Medical Device Technology - Case Studies For personal use only Hydrix has an enviable track record in developing first-to-market technologies Micro-X Clever Culture Systems AngelMed Guardian Rex Bionics The key development partner in the first carbon Key role developing first of World first implanta
Slide 13: Consumer & Industrial - Leadership in connected technologies
Consumer & Industrial - Leadership in connected technologies For personal use only Demand for new, smart connected technologies to create safer more productive work places & better environmental outcomes The Internet of Things Hydrix leads in the development of communications and monitoring technolo
Slide 14: Consumer & Industrial - Case Studies
Consumer & Industrial - Case Studies For personal use only Solving complexity and delivering novel solutions in an increasingly connected world IoT enabled water management Iota OneBox Process innovation Rail Hydrix selected after global capabilities search to Hydrix created a connected Breakthrough
Slide 15: Defence and Aerospace - Expanding market opportunity
Defence and Aerospace - Expanding market opportunity For personal use only Market sector spending drives demand for Hydrix’ highly specialised engineering capabilities Building relationships, driving growth Expanding Hydrix market presence in defence and aerospace by leveraging our highly talented i
Slide 16: Defence and Aerospace - Case Studies
Defence and Aerospace - Case Studies For personal use only Our clients rely on Hydrix’ capabilities to keep people safe and to perform at the highest levels Thomas Global Systems Collins Class Submarines Chemring Group JTAC program Hydrix partnered with Thomas Global Systems to Engineering support p
Slide 17: Hydrix is well placed for future growth and value creation
Hydrix is well placed for future growth and value creation For personal use only • Increasing global demand for advanced engineering, regulatory & design services built over 12+ yrs Strategy & Vision • Recognised sector specialty in: Medical Technology, Consumer & Industrial and Defense & Aerospace
Slide 18: Disclaimer
Disclaimer For personal use only This presentation has been prepared by Hydrix Limited (the “Company” or “Hydrix”). This presentation is being provided to investors for the sole purpose of providing preliminary background financial and other information to enable recipients to review the business ac
Slide 19: Appendix: Board & Corporate Overview
For personal use only Appendix Board & Corporate Overview
Slide 20: Board & Executive Leadership - expertise across multiple disciplines
Board & Executive Leadership - expertise across multiple disciplines For personal use only The Hydrix Board and Executive possess highly relevant, diverse industry experience in strategy, governance, finance and capital markets, technology, IP, human resources, business development, marketing and ma
Slide 21: Key Personnel – subject matter expertise, deep industry relationships
Key Personnel – subject matter expertise, deep industry relationships For personal use only Name Title Biography Peter Lewis Chief Executive Officer 30+ years of international business development in Medtech & advanced technologies, across Asia, US & Europe, with ~$1bn new technology business genera
Slide 22: Key Personnel – subject matter expertise (cont'd)
Key Personnel – subject matter expertise, deep industry relationships (cont’d) For personal use only Name Title Biography Kim Lester Chief Technology Officer 25+ years experience in leading engineering teams, across diverse market technologies including biomedical instrumentation, sonar systems, com
Slide 23: Hydrix – a corporate snapshot
Hydrix – a corporate snapshot For personal use only Capital Structure (as at 7 October 2019) Share Price History Ticker HYD $0.06 Share Price ($) 1 Share Price $0.029 $0.05 2 Shares on Issue (m) 669.3 $0.04 5 Options and Performance Rights (m) 41.4 4 7 6 $0.03 3 Market Capitalisation (diluted) ($m)
Slide 24: hydrix.com contact details
For personal use only hydrix.com 30-32 Compark Circuit Mulgrave VIC 3170 Australia ASX:HYD Page 24 Hydrix Ltd | Investor Presentation | October 2019